Chung‐Pin Li

机构：Taipei Veterans General Hospital · ORCID：0000-0003-2123-8264

发表论文 206 篇 · 总被引 8321 次 · h-index 44

代表论文

• Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy (2024 · ACS Nano · 被引 59)
• Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis (2024 · Advanced Science · 被引 44)
• Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial (2023 · EClinicalMedicine · 被引 33)
• Efficacy and safety of abemaciclib alone and with PI3K / mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial (2023 · Cancer Medicine · 被引 20)
• Clinical impact of pharmacogenetic risk variants in a large chinese cohort (2025 · Nature Communications · 被引 13)
• Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation (2023 · Biomedical Journal · 被引 10)